Presentation is loading. Please wait.

Presentation is loading. Please wait.

Acknowledgment: EPIET/EUPHEM

Similar presentations


Presentation on theme: "Acknowledgment: EPIET/EUPHEM"— Presentation transcript:

1 Acknowledgment: EPIET/EUPHEM
Choice of reference group for comparison Tunis, 29th October 2014 Acknowledgment: EPIET/EUPHEM Dr Adela Paez MediPIET Scientific Coordinator – ECDC, Sweden

2 Learning objectives Source population
How to choose your comparison group: What is a good control?

3 Epidemiologists .... compare
occurrence of outcome depending on presence or absence of exposure disease incidence in different time-periods in a population First, we need to understand what is the source population!

4 Cases Controls Source population Exposed Sample Unexposed
The source population is the source of the cases The control group is the sample of the source population representative with regard to exposure Controls

5 The control group “The comparison group serves to provide
an estimate of the exposure distribution in the source population from which the cases originate.” Rothman KJ, 1986

6 Control characteristics
If controls represent source population, they need to: be representative of exposures in source population be identified as cases if they had disease under study have same exclusion and restriction criteria as cases

7 Example of an outbreak 32 cases of Salmonella Enteritidis
Granada, Spain (population 230,000) onset through September 2014 age range 15 – 48 years 19 male, 13 female Not belonging to a defined group such as attendants of a common event, etc. No recent travel abroad What type of study would you conduct? What is the source population?

8 Source population Residents of Granada aged above 14 years
during September 2014 who have not recently travelled abroad

9 Source population Residents of Granada aged above 14 years
during September 2014 who have not recently travelled abroad Controls should then be representative of this population

10 Case definition Resident of Granada aged above 14 years with isolate of Salmonella Enteritidis in faecal sample during September 2014 Exclusion: Travel abroad in week before illness

11 How to select controls? Aim for random sample of source population
Not always feasible

12 Selecting controls (examples)
Population / community General practitioners Neighbourhood Friends or acquaintances Hospital

13 Population / community controls
Is there a list or register of source population? Such a list should be complete contain all cases be readily accessible identify specified characteristics, e.g. age Take random sample

14 or... random digit dialling
using residential directories or mobile numbers quick and easy but may be biased in selection telephone ownership availability geographical area participation

15 Population / community controls
Advantages Best choice if the source population = community Good representation of the source population Cost and time efficient Disadvantages Possible only in countries where population register exist Depends on the completeness of register

16 General practitioners
Advantages well defined catchment population easily accessible cost and time efficient Disadvantages underrepresentation of mobile population underrepresentation of private care users possible only in countries where GP registration required by law

17 Neighbourhood controls
Advantages no need for population register similar socio-economic status and environmental exposure Disadvantages might be too similar to cases low co-operation may be time consuming, expensive

18 Friends / family controls
Advantages Good matching for social and genetic factors Can be quick and easy People motivated to participate Disadvantages Effectively link the cases and controls May not be able to detect a difference in exposure of importance

19 Hospital controls Advantages Disadvantages
useful if all cases identified from hospital register easy to identify cost and time efficient Disadvantages different catchments for different diseases may not be representative of source population overmatching on exposures for other diseases

20 Controls may not be easy to find
Representative of exposure Exposure should not be a criteria for selecting

21 Example of an outbreak 32 cases of Salmonella Enteritidis
Granada, Spain (population 230,000) onset through September 2014 age range 15 – 48 years 19 male, 13 female no recent travel abroad

22 Source population Residents of North Yorkshire aged above 14 years
during April 2012 who have not recently travelled abroad Controls should then be representative of this population

23 Which reference group ? How would you select controls ? (2 minutes!)
You are in charge of the case control study! How would you select controls ? No population register or list is available Please discuss with a person next to you (2 minutes!)

24 Some common questions Immune populations 100% ill
Non-cases as controls

25 1. Immune subjects Difficult to identify their immune status
May have been cases in the past Not part of the source population May introduce bias and under-estimation of effect OR towards 1

26 2. Which control group if 100% ill ?
What if close to 100% of population ill? Try to have severity Cases: severe cases Control group: less severe cases

27 Outbreak of S. Enteritidis in a Kebab restaurant, North East London February 2005
Food specific attack rates of severe case (AR), relatives risks (RR), 95% confidence intervals (95% CI) amongst cases. Food eaten Food not eaten Severe Total AR% RR 95% CI Salad 10 12 83.3 32 71 45.1 1.9 Chips 11 14 78.5 31 69 44.9 1.8 Sauce 59 52.5 24 45.8 1.2 57 54.4 26 42.3 1.3 Source: Giraudon I et al, EPIET, London HPA

28 Low attack rate: non-cases likely to represent exposure in source pop
3. Non-cases as controls Cases Low attack rate: non-cases likely to represent exposure in source pop Non- cases Source population start end High attack rate: non-cases unlikely to represent exposure in source population Cases Source population Non- cases start end

29 Outbreak of food borne disease in a nursing home
Outbreak of food borne disease in a nursing home. 100 residents, 40 cases Cohort Source Population Non cases Cases ARe = 60% ARu = 10% RR = 6 E 36 24 60 E 4 36 40

30 Outbreak of food borne disease in a nursing home
Outbreak of food borne disease in a nursing home. 100 residents, 40 cases Cohort Potential control groups Sample Non cases Source Population Non cases Cases E 36 24 60 12 E 4 36 40 18 RR = 6 OR = 13.5

31 Outbreak of food borne disease in a
nursing home. 100 residents, 40 cases Cohort Potential control groups Sample Source Population Source Population Sample Non cases Non cases Cases E 36 24 60 12 30 4 36 40 18 20 E RR = 6 OR = 13.5 OR = 6

32 To sum up…

33 Key points in choosing controls
Define source population Think of the cohort you could have done Aim for representative sample Review pros and cons of available options

34 Characteristics of good controls
Come from the same population as the cases Have the same opportunity of exposure as cases Could be recruited as cases if diseased Have exposure window identical to cases

35 Dealing with imperfect control groups
Examine the limitations of your control group with respect to each criteria Assess in which way the limitation will affect the odds ratio Interpret your results in light of this review

36 Conclusions No control group is perfect
Consider the advantages and disadvantages of the available options Aim to minimise error within constraints of resources and urgency of study

37 Be prepared to defend your choice…

38 Research question (1/2) 12% Hepatitis C Virus (HCV) prevalence in Egypt How would you identify current risk factors for HCV infection? What type of study would you conduct? Hint: we need to identify new HCV infections Difficulty: the majority (80%) of acute HCV infections are asymptomatic The highest HCV prevalence in the world occurs in Egypt at an estimated 12% [1], i.e. 10 to 20 fold higher than in Northern Europe [2] or in the United States [3]. The bulk of chronic infection is age-related [4] and occurs among persons of rural origin. Cohort studies have estimated a 9% prevalence and 0.8/ 1000 person-years incidence in Upper Egypt, and a 24% prevalence and 6.8/1000 incidence in the Nile Delta [5,6]. The widespread schistosomiasis treatment campaigns with intravenous tartar emetic, carried out in the countryside in the 60’s- early 80’s, ignited this epidemic through reuse of insufficiently sterilised needles and syringes [7]. Since then, cross-sectional studies have shown unsafe injection practices, history of blood transfusion, invasive medical procedures, and instrument-assisted birth deliveries as associated with HCV infection [8–10]. Intra-familial transmission may also have played an important role, as evidenced in two recent cohort studies

39 Research question (1/2) Provided you conduct a case-control study with acute symptomatic hepatitis C patients identified at the Fever Hospitals in Cairo, How would you select controls? The highest HCV prevalence in the world occurs in Egypt at an estimated 12% [1], i.e. 10 to 20 fold higher than in Northern Europe [2] or in the United States [3]. The bulk of chronic infection is age-related [4] and occurs among persons of rural origin. Cohort studies have estimated a 9% prevalence and 0.8/ 1000 person-years incidence in Upper Egypt, and a 24% prevalence and 6.8/1000 incidence in the Nile Delta [5,6]. The widespread schistosomiasis treatment campaigns with intravenous tartar emetic, carried out in the countryside in the 60’s- early 80’s, ignited this epidemic through reuse of insufficiently sterilised needles and syringes [7]. Since then, cross-sectional studies have shown unsafe injection practices, history of blood transfusion, invasive medical procedures, and instrument-assisted birth deliveries as associated with HCV infection [8–10]. Intra-familial transmission may also have played an important role, as evidenced in two recent cohort studies

40 MediPIET Scientific Coordinator
Thank you! Dr Adela Paez MediPIET Scientific Coordinator

41 References Rothmann KJ, Greenland S. Modern epidemiology. Lippincott-Raven 1998. Hennekens CH, Epidemiology in Medicine. Lippincott-Williams and Wilkins 1987.

42 Investigation 2 Neonatal ward of hospital X
30 cases of Klebsiella pneumoniae (2 deaths) The hospital epidemiologist wants to identify potential risk factors How would you select controls?

43 Investigation 3 250 cases of tick-borne encephalitis (TBE) reported anually in two regions (population: 8 milion) of country X 10% of infected develop disease Infection and vaccination lead to long-lasting immunity Risk factors not well established Contact with ticks (occupational and recreational outdoor activities) How would you select controls to identify risk factors?

44 Investigation 4 In January 2014, the Public Health Agency of Sweden observed a nationwide increase in notified listeriosis cases between October 2013 and March 2014. Isolates from 32 cases had identical Pulsed Field Gel Electrophoresis (PFGE) patterns, suggesting a common source. The median age of cases was 77 years and 23 (72%) were female. It’s now June How would you select the controls? What questions would you ask?

45 What if: Only non-cases as controls?
If attack rate is low, non-cases likely to represent exposures in source population can use them as controls If attack rate is high, non-cases unlikely to represent exposure in source population OR may be over-estimated More accurate not to exclude cases from control group Concept of case-cohort studies!

46 Case-cohort design Aim of control group: properly reflect the exposure in the source population Source pop originally includes people who will later can develop the disease Controls selected from all individuals at risk at the start of the study sampled regardless whether or not they will fall ill No need to document disease status among controls OR estimates relative risk


Download ppt "Acknowledgment: EPIET/EUPHEM"

Similar presentations


Ads by Google